Baudax Bio, Inc. (58) | Intellectual Property (2)
- Third Amendment to License Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC and Baudax Bio, Inc (Filed With SEC on August 21, 2020)
- Amendment to License Agreement, dated October 21, 2019, by and between Cornell University and Recro Pharma, Inc (Filed With SEC on February 13, 2020)